@RAH00084 6000 would have garnered interest, but CC has moved the goalposts with 6203.....
Then there is the dual warhead and lots more to come.
Methinks CC is running up that hill while BP is trying to catch her. How high can she take it is the question?
@TVR5AVCT A strategic move methinks! AI, however credible, is not real world.
This demonstrates high confidence in the platform, at some point an RNS with real data may drop that validates this AI model - a massive 'told you so' moment.
@TVR5AVCT@US_FDA@avacta True, this is a huge step. It is , in effect, a partial validation of the whole platform too.
Great work, kudos to the Avacta team.
@tom_the_bomb__ That's one hell of a typo!
Maybe switched titles on the set of slides for the next (unannounced as yet) meeting? Now, wouldn't that be nice?
@tom_the_bomb__ Today's RNS is about the data only - great data too.
Behind the scenes, commercial opportunities abound, FDA included. This duck is paddling fast out of sight.
Superb commercial news will come - soon.